Real-world, long-term evaluation of the tolerability and therapy retention of Epidiolex® (cannabidiol) in patients with refractory epilepsy
Darina Georgieva, James K. Langley, Katherine Hartkopf, Lisa Hawk, Amanda Margolis, Aaron F. Struck, Elizabeth A. Felton, David Hsu, Barry E. Gidal
Topics & Concepts
TolerabilityDiscontinuationMedicineClobazamAdverse effectEpilepsyInternal medicineDravet syndromeRefractory (planetary science)PediatricsPsychiatryAstrobiologyPhysicsEpilepsy research and treatmentTuberous Sclerosis Complex ResearchCannabis and Cannabinoid Research